Mission Testing PLC
26 June 2002
26 June 2002
MISSION TESTING PLC
Mission Testing plc ('Mission Testing' or 'the Company') announces that Martin
Adcock, a director of the Company, has today exercised share options for 147,755
ordinary shares of 10p each ('Ordinary Shares') at 16.92p per share. Following
the exercise of these options, Mr. Adcock will immediately sell 61,371 Ordinary
Shares to the trustees of the Company's Executive Share Option Plan in order to
settle tax and national insurance liabilities arising. Mr. Adcock's resultant
shareholding in the Company is 86,384 Ordinary Shares, representing 0.5 per cent
of the issued share capital in the Company.
Mission Testing has applied for the 147,755 Ordinary Shares to be admitted to
trading on the Alternative Investment Market. Trading is expected to commence in
these shares on 2 July 2002.
For further information, please contact
Carl Thompson, Finance Director 01293 457123
Mission Testing plc
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.